If Teva’s search for a new president and chief executive officer this year was a long-winded one, then the Israeli firm’s chosen leader has wasted no time in making sweeping changes to the company once he was firmly ensconced in the chair.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?